306 related articles for article (PubMed ID: 26073772)
1. Therapeutic targets for the treatment of hepatitis E virus infection.
Kenney SP; Meng XJ
Expert Opin Ther Targets; 2015; 19(9):1245-60. PubMed ID: 26073772
[TBL] [Abstract][Full Text] [Related]
2. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
[TBL] [Abstract][Full Text] [Related]
3. Targeting proteostasis of the HEV replicase to combat infection in preclinical models.
Zhang F; Xu LD; Zhang Q; Wang A; Yu X; Liu S; Chen C; Wu S; Jin J; Lin A; Neculai D; Zhao B; Feng XH; Liang T; Xu P; Huang YW
J Hepatol; 2023 Apr; 78(4):704-716. PubMed ID: 36574921
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients.
Cordts SE; Schneble L; Schnitzler P; Wenzel JJ; Vinke T; Rieger S; Fichtner A; Tönshoff B; Höcker B
Pediatr Nephrol; 2018 Jul; 33(7):1215-1225. PubMed ID: 29500631
[TBL] [Abstract][Full Text] [Related]
5. An ethanol extract of Lysimachia mauritiana exhibits inhibitory activity against hepatitis E virus genotype 3 replication.
Jin SE; Kim JE; Kim SY; Park BJ; Song YJ
J Microbiol; 2017 Dec; 55(12):984-988. PubMed ID: 29214492
[TBL] [Abstract][Full Text] [Related]
6. Antiviral Candidates for Treating Hepatitis E Virus Infection.
Netzler NE; Enosi Tuipulotu D; Vasudevan SG; Mackenzie JM; White PA
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30885901
[TBL] [Abstract][Full Text] [Related]
7. Cutthroat trout virus as a surrogate in vitro infection model for testing inhibitors of hepatitis E virus replication.
Debing Y; Winton J; Neyts J; Dallmeier K
Antiviral Res; 2013 Oct; 100(1):98-101. PubMed ID: 23916729
[TBL] [Abstract][Full Text] [Related]
8. Zinc: A Potential Antiviral Against Hepatitis E Virus Infection?
Kaushik N; Anang S; Ganti KP; Surjit M
DNA Cell Biol; 2018 Jul; 37(7):593-599. PubMed ID: 29897788
[TBL] [Abstract][Full Text] [Related]
9. Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation.
Allweiss L; Gass S; Giersch K; Groth A; Kah J; Volz T; Rapp G; Schöbel A; Lohse AW; Polywka S; Pischke S; Herker E; Dandri M; Lütgehetmann M
J Hepatol; 2016 May; 64(5):1033-1040. PubMed ID: 26805671
[TBL] [Abstract][Full Text] [Related]
10. The Viral ORF3 Protein Is Required for Hepatitis E Virus Apical Release and Efficient Growth in Polarized Hepatocytes and Humanized Mice.
Sari G; Zhu J; Ambardekar C; Yin X; Boonstra A; Feng Z; Vanwolleghem T
J Virol; 2021 Nov; 95(23):e0058521. PubMed ID: 34523963
[TBL] [Abstract][Full Text] [Related]
11. Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122.
Haldipur B; Bhukya PL; Arankalle V; Lole K
J Virol; 2018 Jun; 92(11):. PubMed ID: 29540601
[TBL] [Abstract][Full Text] [Related]
12. The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo.
Todt D; Moeller N; Praditya D; Kinast V; Friesland M; Engelmann M; Verhoye L; Sayed IM; Behrendt P; Dao Thi VL; Meuleman P; Steinmann E
Antiviral Res; 2018 Sep; 157():151-158. PubMed ID: 30036559
[TBL] [Abstract][Full Text] [Related]
13. [Chronic Hepatitis E Virus Infection and Treatment in Organ Transplant Recipients].
Chen S; Wei F; Wu T; Xia N
Bing Du Xue Bao; 2015 May; 31(3):293-8. PubMed ID: 26470537
[TBL] [Abstract][Full Text] [Related]
14. The macrolide antibiotic azithromycin potently inhibits hepatitis E virus in cell culture models.
Miao Z; Zhang R; Yu P; Li Y; Pan Q; Li Y
Int J Antimicrob Agents; 2021 Sep; 58(3):106383. PubMed ID: 34157403
[TBL] [Abstract][Full Text] [Related]
15. Isocotoin suppresses hepatitis E virus replication through inhibition of heat shock protein 90.
Nimgaonkar I; Archer NF; Becher I; Shahrad M; LeDesma RA; Mateus A; Caballero-Gómez J; Berneshawi AR; Ding Q; Douam F; Gaska JM; Savitski MM; Kim H; Ploss A
Antiviral Res; 2021 Jan; 185():104997. PubMed ID: 33326835
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of hepatitis E virus replication by peptide-conjugated morpholino oligomers.
Nan Y; Ma Z; Kannan H; Stein DA; Iversen PI; Meng XJ; Zhang YJ
Antiviral Res; 2015 Aug; 120():134-9. PubMed ID: 26086884
[TBL] [Abstract][Full Text] [Related]
17. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of hepatitis E virus replication by proteasome inhibitor is nonspecific.
Xu L; Zhou X; Peppelenbosch MP; Pan Q
Arch Virol; 2015 Feb; 160(2):435-9. PubMed ID: 25476751
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis E - A new era in understanding.
Krzowska-Firych JM; Lucas C; Lucas G; Tomasiewicz K
Ann Agric Environ Med; 2018 Jun; 25(2):250-254. PubMed ID: 29936817
[TBL] [Abstract][Full Text] [Related]
20. Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication.
Wang Y; Wang W; Xu L; Zhou X; Shokrollahi E; Felczak K; van der Laan LJ; Pankiewicz KW; Sprengers D; Raat NJ; Metselaar HJ; Peppelenbosch MP; Pan Q
Antimicrob Agents Chemother; 2016 May; 60(5):2834-48. PubMed ID: 26926637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
